The chemotherapy source book /
Clasificación: | Libro Electrónico |
---|---|
Otros Autores: | |
Formato: | Libro |
Idioma: | Inglés |
Publicado: |
Philadelphia :
Wolters Kluwer Health/Lippincott Williams & Wilkins,
c2008.
|
Edición: | 4th ed. |
Temas: | |
Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Scientific basis of cancer chemotherapy
- Norton-simon hypothesis
- Drug resistance
- Principles of chemotherapy
- Clinical trials
- Hematopoietic growth factors
- Biologic response modifiers: principles of biotherapy
- Intraventricular and intrathecal therapy
- Intraperitoneal chemotherapy
- Continuous intravenous infusion chemotherapy
- Intraarterial chemotherapy
- Isolated regional therapy
- Hematopoietic stem cell transplantation
- Oral toxicity
- Dermatologic toxicity
- Extravasation
- Hypersensitivity reactions
- Ocular side effects of chemotherapy
- Cardiotoxicity of cancer therarpy
- Pulmonary toxicity of antineoplastic therapy
- Gastrointestinal complications of chemotherapy
- Hepatotoxicity of chemotherapeutic agents
- Renal and electrolyte abnormalities due to chemotherapy
- Chemotherapy-induced peripheral neuropathy
- Vascular toxicity of antineoplastic agents
- Second malignancies after chemotherapy
- Chemotherapy in pregnancy
- Gonadal complications and teratogenicity of cancer therapy
- Central venous access for chemotherapy
- Systemic therapy for advanced melanoma
- General issues in brain tumor chemotherapy
- Chemotherapy of head and neck cancer
- Chemotherapy of lung cancer
- Breast cancer
- Gastrointestinal cancer
- Endocrine tumors
- Chemotherapy of genitourinary cancers
- Chemotherapy of gynecologic cancers
- Chemotherapy of carcinoma of unknown primary site
- Chemotherapy of bone and soft tissue sarcomas
- Chemotherapy for pediatic solid tumors
- Chemotherapy of hodgkin's lymphoma
- Non-hodgkin's lymphoma
- Acute myeloid leukemia, aucte lymphoblastic leukemia, and chronic lymphocytic leukemia
- Chemotherapy of the myelodysplastic syndromes
- Management of myeloproliferative disorders and chronic myeloid leukemia
- Chemotherapy of multiple myeloma and other plasma cell disorders.